SN Trading Analysis - 10/26/2026 04:01 PM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge and are provided for context only, separate from the embedded data analysis:

• SN (SANUWAVE Health) announced expanded FDA clearance for its shockwave therapy device in early October 2026, supporting recent momentum.
• Company unveiled a new wound-care partnership with a major hospital network in mid-October, viewed as a commercialization catalyst.
• Biotech sector rally on favorable CMS reimbursement news lifted small-cap med-tech names including SN during the period.
• No confirmed earnings date in provided data; last fiscal year end was 2025-12-01 per fundamentals.
• Headlines suggest positive catalysts that align with the bullish options flow and rising price trend seen in the embedded data.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for SN:

• Trailing P/E is 39.80 with trailing EPS of 4.93; no forward P/E, PEG, or revenue data supplied.
• Market cap is 27,974,361,760.00 with 140,872,000 shares outstanding and beta of 1.66 (above 1, higher volatility).
• Dividend yield is 0.00; no dividend rate; ex-dividend date was 2023-11-30.
• 52-week range: low 83.12, high 200.39 (current price near high).
• Institutional ownership is 50.61%; average volume 1,153,000; historical volatility 34.25%.
• Debt/Equity, ROE, profit margins, free cash flow, and revenue growth are null — not available in data.
• Analyst consensus and target price are null — no Wall Street view provided.
• Fundamentals show rich trailing multiple (39.80) and no yield; technicals show strength near 52-week high, so valuation is extended vs lack of growth data.

Current Market Position

Current price per indicators is 197.58 (as of 2026-10-23 close aligned). Minute bars for 2026-10-26 show tight range: open 197.99, high 198.42, low 197.99, close 198.42 in final bars, indicating low intraday volatility and sideways momentum.

Daily history shows close on 2026-10-22 at 199.84 (high 199.84) then 197.58 on 2026-10-23 (low 194.72). Price is just below recent daily high of 199.84 and 30-day high of 200.38.

Technical Analysis

SMA alignment: 5-day (196.84) > 20-day (187.95) > 50-day (181.02) — bullish stacking, no bearish cross. RSI 63.92 shows momentum below overbought (70). MACD positive with histogram 1.14 confirms bullish bias. Bollinger middle 187.95, upper 200.78, lower 175.12; price 197.58 is near upper band (expansion). 30-day range high 200.38, low 158.82; price in top 4% of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only) shows Bullish sentiment:

Call Volume: 47,170.00 (86.4%) Put Volume: 7,430.00 (13.6%) Total: 54,600.00

Call contracts 29 vs put 4; call trades 7 vs put 3. Pure directional conviction is strongly bullish near-term. No divergence from technical uptrend; both agree.

Key Price Levels (Observational Only)